KERI HOLYOAK: Open Payments
NPI 1578578357 · MIDVALE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154,746 in 353 payments from 20 companies in 2025. Trend: 2023 $85,155 · 2024 $139,766 · 2025 $154,746
Consulting: $62,270Speaker / faculty: $54,985Travel & lodging: $23,097Honoraria: $8,050Food & beverage: $6,345
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 128 | $59,678 |
| GENZYME CORPORATION | 45 | $31,303 |
| Regeneron Healthcare Solutions, Inc. | 59 | $22,294 |
| Galderma Laboratories, L.P. | 37 | $13,154 |
| Organon LLC | 21 | $9,557 |
| PFIZER INC. | 8 | $6,855 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 24 | $6,696 |
| Kowa Pharmaceuticals America, Inc. | 8 | $4,298 |
| Novartis Pharmaceuticals Corporation | 4 | $153 |
| Janssen Biotech, Inc. | 2 | $142 |
Products named: DUPIXENT, Zoryve, NEMLUVIO, VTAMA, Leqselvi, AKLIEF, CIBINQO, TREMFYA.
Industry payments across UT — which companies pay providers there.
